Synopsis: Himadri Speciality Chemical is leveraging its carbon chemistry expertise, deep R&D capabilities, and strategic global partnerships to build an integrated lithium-ion battery materials platform. With commercial anode production, a Rs 1,125 crore cathode...
Synopsis: Sona BLW is entering FY27 with record Q4 numbers, Rs. 1,269 crore cash and a large Rs. 237 billion order book. At a time when tariffs, EV volatility and supply chain resets are troubling global auto suppliers, management believes this disruption could help...
Synopsis: United Breweries is set to announce its Q4FY26 and full-year results tomorrow, with brokerages expecting modest revenue growth, improving margins, and mixed demand trends across markets. Premium portfolio growth, cost efficiencies, and regional performance...
Synopsis: 360 ONE is transitioning from a market-linked, transaction-driven model to a more stable, annuity-led business. With 75% recurring revenue, strong AUM growth, and rising UHNI participation, the company is building predictable income streams. Its diversified...
Synopsis: Crisil’s transformation from a ratings-focused entity to an analytics-driven firm highlights the rising importance of its RAS segment. Strong FY26 growth, margin expansion, AI integration, and global diversification position RAS as a scalable growth engine....
Synopsis: CIE Automotive India’s growth is supported by strong domestic demand and a healthy order pipeline, providing visibility for future expansion. However, weak exports, rising input costs, and global uncertainties pose challenges. Sustaining growth will depend...
Synopsis: Ather Energy’s Q4FY26 results could mark a major milestone as strong EV demand, dealership expansion, and new platform launches may help the company cross Rs. 1,000 crore in quarterly revenue for the first time. Ather Energy has informed the exchanges that a...
Synopsis: LTTS is undergoing a strategic transformation by exiting low-margin businesses and focusing on AI-led engineering through its Engineering Intelligence framework. While near-term growth remains modest, strong deal wins, margin improvement, and six...
Synopsis: This Pharma-Chemical stock is a global Ibuprofen leader with a large integrated manufacturing base, low debt and new API expansion plans. But the bigger question is whether Paracetamol, non-Ibuprofen APIs, exports and regulated markets can turn this stable...
Synopsis: An ace investor’s portfolio quietly delivered over ₹3.81 crore in dividend income in FY26, with four of his top ten holdings by value driving the bulk of the payout, underscoring the dual benefit of capital appreciation and steady cash flows in a...
